We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Myhealthchecked Plc | LSE:MHC | London | Ordinary Share | GB00BN7K5L93 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.25 | 10.00 | 10.50 | 10.25 | 10.25 | 10.25 | 15 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 22.31M | 1.52M | 0.0292 | 3.51 | 5.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/10/2022 21:58 | McGuinnes, lol | early retirement | |
05/10/2022 20:58 | 7m cash end of June. Record revs July, probably not far behind in August still holiday season. Winter covid sales will pick up. It’s looking good value at 12m cap imo | smackeraim | |
05/10/2022 18:18 | I personally think the new tests are not not selling as good on Amazon however news of new test tests in Boots etc would change sales because suddenly they are in customers faces and with good promotions would get people interested. On a separate note covid products will be flying off the shelves as we speak because it’s rising again so revenue will still be good. On the Covid sales alone we are undervalued and I do believe a takeover is of smaller a smaller company is imminent | tia01 | |
05/10/2022 16:15 | The new tests are pointless they don't tell you anything. | encarter | |
05/10/2022 11:11 | We'll see mcguines, paid derampers are clever and insidious in their tactics. This share is undervalued and the decision to not make public sales forecasts or forward earnings forecasts is frustrating to investors. Understandable as it is the fundamentals remain: MHC has income, cash in bank, product market fit/competitive advantage, NO DEBT, will evaluate an acquisition if one acquisition makes sense, is operating in a growth market. Its a great place to be, now add sales forecasts to the PR/marketing comms please Penny. I for one am dying to know, at least in part, what the future value of my investment could be... | mike2042 | |
05/10/2022 10:11 | Dedicated to "Il Giardiniere Pazzo Italiano", you started this train of thought... !!Breaking News!! Liz Truss has decided to introduce a mandatory "Stupidity" test in the U.K. All members of the public over the age of 18 years will be obliged to take the test. All test results will be made public on a government web site. The tests will be free but members of the public may choose to have a result of 'inconclusive' published by paying an up front fee of 100stg. It is expected that clever people will avail of this offer and the remainder who think they are very clever will be sorely disappointed by their results. Past and present members of government will be exempt from this test, for obvious reasons. The contract to undertake this test has been awarded exclusively to MyHealthChecked PLC, an AIM-quoted pioneering healthcare company based in Cardiff. When interviewed Penny McCormick (AKA Scrooge McCormick), Chief Executive Officer of MyHealthChecked Plc, said: "We are excited to be chosen for this "Stupidity" test which will add greatly to our range of (un)wellness tests. I see this as an opportunity to greatly enhance my earnings as I am not in this business to increase shareholder value. | mcguines | |
05/10/2022 07:32 | The uptake for the 4th and 5th jab is dire. | spacedust | |
05/10/2022 04:54 | Tia people do realise covid is rising, thats why they be again getting their jabs for covid and flu | waldron | |
04/10/2022 23:03 | People don’t realise but Covid is rising and the local hospital trust in Worcestershire has made in mandatory from this week for workers to wear masks again. Covid is rising again so hopefully the share price follows | tia01 | |
04/10/2022 22:10 | All this is happening on this BB is purely because of where the share price is. None of us would give a monkeys if the share price was 10p n penny was milking a million in wages. If the share price was 14p we wouldn't care less about reporting fact ir even figures. The ahttt share price is making our minds go crazy. | spacedust | |
04/10/2022 19:09 | Yes looking back he was positive back in December. | hazl | |
04/10/2022 18:21 | mike2042: Columbarius IS NOT a paid deramper! Until recently the said same Columbarius has been very positive about MHC and Mercia. Columbarius has stated here on at least two occasions that he/she owns many shares in both MHC and Mercia, so to assert that he/she is a deramper does not make any sense. I personally think that Columbarius is extremely angry with MHC/Mercia after reading the financial report and discovering that Penny is milking the company for her own benefit and that she is not being honest in her RNS reporting. I also think that Columbarius should not vent his/her anger on posters here!!! Don't get angry... get even!!! What options do we have here Columbarius? | mcguines | |
04/10/2022 17:26 | columbarius IS a paid deramper!! C'mon, boyo start telling us that MHC is doomed and our invested money is lost... what to do, what to do :-o | mike2042 | |
04/10/2022 17:25 | Why are you here then ? | billy3 | |
04/10/2022 16:35 | If you don’t think selling new tests through boots (because no one is forced to buy them) is not a good thing,then maybe you are in the wrong game and should stick to name calling elsewhere. Well there's a sentence by a cretin which proves my point. Unless one of you wonderkids can make sense of it. He also says the Boots and Lloyds tests for LFTs are hugely profitable so he's Billy3Liar as well. The margins for PCRs were very profitable but the margins on LFTs are rubbish. Cash is going up but the lab closure and all the layoffs contributed to that. Penny has warned revenues will markedly drop off post covid. She's not been putting any of her 300k pay rise in either. She could of course be tight with her own money. Looks like she's still wearing NHS glasses. | columbarius | |
04/10/2022 16:20 | The share price should reflect the companies merits cash position and ability to increase profits. People will say every single share is down. Yet I look at some shares and they keep rising for no reason even in this stock mark turmoil. | spacedust | |
04/10/2022 15:53 | Frustrating share price though as this company has done so well. Look at the financials! | hazl | |
04/10/2022 15:51 | Can't remember now billy. I've been on these boards so long it just washes over me. 8-) | hazl | |
04/10/2022 15:42 | Didn’t he call you patronising Hazl ? | billy3 | |
04/10/2022 15:41 | It's quite exciting I think I have a troll! Nothing's the same with out a little troll to see you through your day. | hazl | |
04/10/2022 15:37 | I do think this is totally oversold though. | hazl | |
04/10/2022 15:35 | I agree with Billy on this occasion....though I do make the odd post about governments,too. It is about visibility and suggestion. Supermarkets,know this, or they wouldn't move everything around frequently. You go in for a piece of cheese and come out with a danish pastry as well. So, yes, if you spot one of the DNA tests,you might just think...hmm might get one of those, if you already had reason to be interested in the first place. | hazl | |
04/10/2022 15:26 | I did not say that they would sell as many as covid tests. It’s about availability. You say people had to buy covid tests. That is correct. Same as no one is forced to buy burgers but they go to McDonald’s. No one is forced to buy a TV but they go to Currys. No one is forced to buy holidays but they go to TUI It’s about availability and brand recognition and as Penny explained, millions hold boots advantage card. Why do you think people go on dragons den etc just trying to get their product in the big retailers. If you don’t think selling new tests through boots (because no one is forced to buy them) is not a good thing,then maybe you are in the wrong game and should stick to name calling elsewhere. | billy3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions